The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.
J&J starts head-to-head PFA trial against Boston Scientific device Read More »
The insurer, a mainstay in government programs like Medicaid and the ACA exchanges that have been wracked by higher spending, successfully controlled costs in the quarter, leading to $1.5 billion in profit.
Centene hikes 2026 profit guidance after buoyant Q1 Read More »
The private equity group plans to accelerate growth of the acquired business, including by empowering it to engage in M&A.
Thermo Fisher inks $1.1B deal to sell microbiology unit to Astorg Read More »
Suketu Upadhyay is headed to biopharma company Incyte. Paul Stellato will step into the CFO role on an interim basis.
Age and specialty increased the likelihood of being sued, according to a new survey from the American Medical Association, with surgeons facing the highest risk.
Frequency of medical liability lawsuits is declining, but risk remains for doctors: AMA Read More »
Cancer cocktails pairing Moderna’s mRNA-4359 with Merck’s Keytruda and Marengo’s invikafusp alfa with Gilead Sciences’ Trodelvy showed promising results, while a complex combination by Agenus and MiNK Therapeutics failed to elicit an overall response.
AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer Read More »
Topline Phase 3 results of survodutide—licensed to Boehringer Ingelheim from Zealand Pharma—are more comparable to Novo Nordisk’s Wegovy than to Eli Lilly’s Zepbound, William Blair analysts said on Tuesday.
Boehringer, Zealand’s obesity drug ‘more akin’ to Novo’s Wegovy in Phase 3 Read More »
AbbVie is setting up a shot to buy Kestrel Therapeutics down the line, as the biotech doses patients in a Phase 1 trial for the oral pan-KRAS inhibitor KST-6051 in solid tumors.
AbbVie sinks talons into KRAS with right to buy Kestrel for up to $1.45B Read More »
Hace menos de un año, unos astrónomos descubrieron un cometa llegado de fuera de nuestro sistema solar. Aunque todavía se desconoce de qué sistema solar proviene este objeto interestelar llamado 3I/ATLAS, una nueva investigación ha revelado algunos detalles sobre l …
El lugar del cosmos en el que se formó el cometa interestelar 3I/ATLAS era exótico Read More »
Los pulpos de hoy en día son animales inteligentes y notablemente adaptables que acechan en los arrecifes, se esconden en grietas o flotan disimuladamente en las profundidades del mar. Pero una nueva investigación sugiere que los primeros ancestros evolutivos de su grupo ostentaron un …
Cuando los mares estaban dominados por pulpos gigantes Read More »
